Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Guadalajara

🇲🇽Mexico

Country: 🇲🇽Mexico

Ownership: Private

Established: 1792-01-01

Employees: -

Market Cap: -

Website: http://www.udg.mx

Clinical Trials

Efficacy of Aspirin and L-arginine in High Risk Preeclamptic

Phase 2

Suspended

Conditions: High Risk Pregnancy

Interventions: Drug: Placebo (for L-arginine)
Drug: L-arginine
Drug: acetylsalicylic acid

First Posted Date: 2016-07-20

Last Posted Date: 2020-11-27

Lead Sponsor: University of Guadalajara

Target Recruit Count: 82

Registration Number: NCT02838030

Locations: 🇲🇽
Antiguo Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico

Capsaicin Effect on Cytokines Profile in Dyslipidemia

Phase 2

Conditions: Dyslipidemia
Overweight or Obesity

Interventions: Drug: Magnesia calcinada
Drug: Capsaicin

First Posted Date: 2016-07-06

Last Posted Date: 2016-07-19

Lead Sponsor: University of Guadalajara

Target Recruit Count: 17

Registration Number: NCT02823912

Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabetic Foot Ulcers

Phase 3

Completed

Conditions: Diabetic Foot Ulcers

Interventions: Drug: Placebo
Drug: Chitosan
Drug: Isosorbide dinitrate

First Posted Date: 2016-06-02

Last Posted Date: 2021-01-12

Lead Sponsor: University of Guadalajara

Target Recruit Count: 68

Registration Number: NCT02789033

Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

Phase 2

Completed

Conditions: Metabolic Syndrome X

Interventions: Drug: Banaba
Drug: placebo

First Posted Date: 2016-05-10

Last Posted Date: 2021-01-14

Lead Sponsor: University of Guadalajara

Target Recruit Count: 24

Registration Number: NCT02767869

Locations: 🇲🇽
Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.

Phase 2

Completed

Conditions: Impaired Glucose Tolerance

Interventions: Drug: Gymnema Sylvestre
Drug: Placebo

First Posted Date: 2016-03-15

Last Posted Date: 2021-02-02

Lead Sponsor: University of Guadalajara

Target Recruit Count: 30

Registration Number: NCT02708966

Locations: 🇲🇽
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

Phase 4

Completed

Conditions: Prediabetes
Impaired Glucose Tolerance
Impaired Fasting Glucose

Interventions: Drug: Dapagliflozin
Drug: Placebo

First Posted Date: 2016-03-07

Last Posted Date: 2020-10-28

Lead Sponsor: University of Guadalajara

Target Recruit Count: 24

Registration Number: NCT02700334

Locations: 🇲🇽
Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Insulin Degludec
Drug: Insulin Glargine

First Posted Date: 2016-02-11

Last Posted Date: 2020-09-28

Lead Sponsor: University of Guadalajara

Target Recruit Count: 12

Registration Number: NCT02680457

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers

Phase 1

Completed

Conditions: Diabetic Foot Ulcer

Interventions: Drug: Pirfenidone with MODD
Drug: Ketanserin

First Posted Date: 2015-12-17

Last Posted Date: 2015-12-17

Lead Sponsor: University of Guadalajara

Target Recruit Count: 60

Registration Number: NCT02632877

Locations: 🇲🇽
Molecular Biology and Gene Therapy Institute, Guadalajara, Jalisco, Mexico
🇲🇽
Hospital Valentín Gómez Farías, Zapopan, Jalisco, Mexico

Evaluation of the Effect of Moderate-intensity Physical Activity on Glycemic Variability

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Physical activity of moderate intensity for 3 days

First Posted Date: 2015-12-03

Last Posted Date: 2018-04-30

Lead Sponsor: University of Guadalajara

Target Recruit Count: 22

Registration Number: NCT02620670

Locations: 🇲🇽
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

Phase 2

Completed

Conditions: Impaired Glucose Tolerance

Interventions: Drug: Placebo
Drug: Chlorogenic acid

First Posted Date: 2015-12-03

Last Posted Date: 2019-08-02

Lead Sponsor: University of Guadalajara

Target Recruit Count: 30

Registration Number: NCT02621060

Locations: 🇲🇽
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy